Abstract:Developing biocompatible, multifunctional and in-situ labeling nanoplatform is high challenging for molecular imaging. Organic derivates melanin nanoparticles (MNPs) holds great potential to be multimodal contrast agents, and have been used for photoacoustic imaging, magnetic resonance imaging, and Cu-64 PET imaging with simple modifications. In order to extend MNPs application in molecular imaging, here a novel radio-nuclide was applied to in-situ labeling of MNPs. Large numbers of active dihydroxyindole/indolequinone groups and natural binding ability of MNPs enabled them to have the ability to label different types of radionuclides which have unique half-life and functions, especially long-life elemental nuclide. This project explored the in-situ labeling methods of organic melanin nanoparticles with a promising diagnostic radionuclides named Iodine-124 (I-124), and using this novel multifunctional organic nanoparticles for preliminary molecular imaging studies. Generally, ultrafine particle size melanin nanoparticles (5.5 nm in diameter) were prepared by ultrasonication method using naturally occurring melanin, then PEG(3500) which had amino group at both ends was used as a stabilizer agent to obtain PEG-MNP nanocarriers (7.5 nm in diameter) with better water solubility and stability. The nanoparticles were full characterized by dynamic light scattering (DLS), transmission electron microscope (TEM) and H-1 NMR, respectively. Then, one kind of elemental nuclide was labeled. Classic iodine labeled method with N-Bromo Succinimide (NBS) was used as oxidant to oxidize active dihydroxyindole/indolequinone ring of PEG-MNP for electrophilic substitution reaction labeling I-124 (100.8 h). This reaction rate is extremely fast (60 s reaction time) and high labelling yield (>99%). The I-124 was labeled successfully and in-situ labeled PEG-MNP nanocarriers were obtained. After that, I-124 and I-124-PEG-MNP were used to further preclinical evaluation by micro-PET imaging. Micro-PET images were collected at 2 h, 24 h and 48 h after intravenous injection 7.4 MBq I-124 and I-124-PEG-MNP in normal Kunming mice (n=3). The ROI target area of heart, liver and thyroid were delineated for semi-quantitative analysis. Then, in order to verify the imaging ability of I-124-PEG-MNP in solid tumor. We built human pancreatic cancer BxPC3 xenograft model (n=3), and Micro-PET scans were performed at different time points. Results showed that the labeling rate of I-124 on PEG-MNP was 99.9%. And the radiochemical purity in vitro stability of I-124-PEG-MNP in 96 h was more than 90%. Micro-PET images showed that I-124-PEG-MNP had no obvious thyroid uptake which indicated no de-marking in mice. The radio-distribution of I-124 and I-124-PEG-MNP was substantially different in liver and thyroid (P<0.001). In vivo semi-quantitative analysis showed that the radio uptakes of organs were consistent with the distribution of nanoparticles. And the PET imaging of xenograft mice showed that I-124-PEG-MNP can utilize the enhanced permeability and retention effect (EPR) to be significantly enriched at the tumor and retained in the tumor site for more than 48 h. PEG-MNP has the ability to label long half-life nuclide I-124. This research provides an experimental basis for further construction of long-circulation multimodal imaging probes.

Design and Synthesis of 111In-Ccpm-rgd Nanoparticles for Dual-modality Molecular Imaging

Cyclic-Arginine-Glycine-Aspartic (C-Rgd) Conjugated Polymeric Micelles for SPECT/NIRF Dual-Modality Tumor Imaging

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

Synthesis and Radiolabeling of (111)In-Core-cross Linked Polymeric Micelle-Octreotide for Near-Infrared Fluoroscopy and Single Photon Emission Computed Tomography Imaging.

Novel Dual-Function Near-Infrared II Fluorescence and PET Probe for Tumor Delineation and Image-Guided Surgery.

Design, Synthesis And Evaluation Of Dual-Modality Glyco-Nanoparticles For Tumor Imaging

Novel lanthanide–polymer complexes for dye-free dual modal probes for MRI and fluorescence imaging

Radiolabeled PET/MRI Nanoparticles for Tumor Imaging

Application Analysis of 124I-PPMN for Enhanced Retention in Tumors of Prostate Cancer Xenograft Mice.

RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis

Radiolabeled AIE Probes As Dual-modality Imaging Agents for PET/NIR-II Fluorescence-Guided Photothermal Therapy

One-step Radiosynthesis of 18F-Alf-nota-rgd2 for Tumor Angiogenesis PET Imaging

Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice

Radiolabeled Human Protein-Functionalized Upconversion Nanoparticles for Multimodal Cancer Imaging

99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast ( T 1 / T 2 ) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis

Rational Design of High Performance Nanotheranostics for NIR-II Fluorescence/magnetic Resonance Imaging Guided Enhanced Phototherapy.

Dual-Mode Contrast Agents with RGD-Modified Polymer for Tumour-Targeted US/NIRF Imaging

Preparation and Preliminary Molecular Imaging Study of 124I In-Situ Labeled Organic Melanin Nanoparticles

Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03

Preliminary studies of 68Ga-NODA-USPION-BBN as a dual-modality contrast agent for use in positron emission tomography/magnetic resonance imaging

A Novel Αvβ3 Integrin-Targeted NIR-II Nanoprobe for Multimodal Imaging-Guided Photothermal Therapy of Tumors in Vivo